Literature DB >> 6465671

Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea.

V Hoffstein, N Zamel, E A Phillipson.   

Abstract

We examined the relationship between lung volume and pharyngeal cross-sectional area in 9 obese patients with obstructive sleep apnea and 10 age-matched, obese subjects without sleep apnea. Pharyngeal area was measured in the upright, seated posture using an acoustic reflection technique. Measurements were made at a rate of 5 per second during a slow exhalation from total lung capacity (TLC) to residual volume (RV). In the control subjects, the mean +/- SE pharyngeal area was 5.6 +/- 0.2 cm2 at TLC, and decreased by 30 +/- 5% over the vital capacity range to 3.9 +/- 0.3 cm2 at RV. In contrast to the control subjects, in patients with obstructive sleep apnea, pharyngeal area was 5.0 +/- 0.2 cm2 at TLC, and decreased by 54 +/- 6% over the vital capacity range to 2.3 +/- 0.3 cm2 at RV. The difference in pharyngeal area between the patients and control subjects was significant at all lung volumes below TLC, as was the difference in the magnitude of change in pharyngeal area with change in lung volume. The results indicate that in obese patients with obstructive sleep apnea, pharyngeal cross-sectional area is abnormally small, and varies considerably with changes in lung volume. The beneficial effects of weight reduction in such patients may relate to the coincident increase in functional residual capacity, causing an increase in upper airway size.

Entities:  

Mesh:

Year:  1984        PMID: 6465671     DOI: 10.1164/arrd.1984.130.2.175

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  49 in total

Review 1.  Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome.

Authors:  R B Fogel; A Malhotra; D P White
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 2.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

3.  Determination of respiratory phase during acquisition of airway cine MR images.

Authors:  Maninder Kalra; Lane F Donnelly; Keith McConnell; Kendall O'Brien; Jaskaran Sandhu; James Johnson; Raouf S Amin
Journal:  Pediatr Radiol       Date:  2006-06-29

Review 4.  Pathophysiology of adult obstructive sleep apnea.

Authors:  Danny J Eckert; Atul Malhotra
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

5.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

6.  Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea.

Authors:  Raphael C Heinzer; Michael L Stanchina; Atul Malhotra; Robert B Fogel; Sanjay R Patel; Amy S Jordan; Karen Schory; David P White
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

7.  Heritability of upper airway dimensions derived using acoustic pharyngometry.

Authors:  S R Patel; J M Frame; E K Larkin; S Redline
Journal:  Eur Respir J       Date:  2008-06-25       Impact factor: 16.671

8.  The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility.

Authors:  Robert L Owens; Atul Malhotra; Danny J Eckert; David P White; Amy S Jordan
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

Review 9.  Flow-regulatory function of upper airway in health and disease: a unified pathogenetic view of sleep-disordered breathing.

Authors:  S S Park
Journal:  Lung       Date:  1993       Impact factor: 2.584

Review 10.  Acoustic reflection: review and clinical applications for sleep-disordered breathing.

Authors:  John S Viviano
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.